ENST00000612323.4:c.117T>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000612323.4(TMEM230):c.117T>A(p.Pro39Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,606,410 control chromosomes in the GnomAD database, including 12,030 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2445 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9585 hom. )
Consequence
TMEM230
ENST00000612323.4 synonymous
ENST00000612323.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.668
Publications
18 publications found
Genes affected
TMEM230 (HGNC:15876): (transmembrane protein 230) This gene encodes a multi-pass transmembrane protein that belongs to the TMEM134/TMEM230 protein family. The encoded protein localizes to secretory and recycling vesicle in the neuron and may be involved in synaptic vesicles trafficking and recycling. Mutations in this gene may be linked to familial Parkinson's disease. [provided by RefSeq, Mar 2017]
TMEM230 Gene-Disease associations (from GenCC):
- Parkinson diseaseInheritance: SD, AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 20-5106293-A-T is Benign according to our data. Variant chr20-5106293-A-T is described in ClinVar as Benign. ClinVar VariationId is 1265859.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.668 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.291 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM230 | NM_001330987.2 | c.117T>A | p.Pro39Pro | synonymous_variant | Exon 3 of 4 | NP_001317916.1 | ||
| TMEM230 | NM_001009924.2 | c.117T>A | p.Pro39Pro | synonymous_variant | Exon 4 of 5 | NP_001009924.1 | ||
| TMEM230 | NM_001009925.2 | c.117T>A | p.Pro39Pro | synonymous_variant | Exon 3 of 4 | NP_001009925.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.152 AC: 23120AN: 152060Hom.: 2441 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
23120
AN:
152060
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0997 AC: 24264AN: 243446 AF XY: 0.0964 show subpopulations
GnomAD2 exomes
AF:
AC:
24264
AN:
243446
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.107 AC: 155483AN: 1454232Hom.: 9585 Cov.: 33 AF XY: 0.105 AC XY: 76158AN XY: 723318 show subpopulations
GnomAD4 exome
AF:
AC:
155483
AN:
1454232
Hom.:
Cov.:
33
AF XY:
AC XY:
76158
AN XY:
723318
show subpopulations
African (AFR)
AF:
AC:
10115
AN:
32884
American (AMR)
AF:
AC:
3046
AN:
42464
Ashkenazi Jewish (ASJ)
AF:
AC:
3923
AN:
25766
East Asian (EAS)
AF:
AC:
5
AN:
39600
South Asian (SAS)
AF:
AC:
5249
AN:
84476
European-Finnish (FIN)
AF:
AC:
3656
AN:
53358
Middle Eastern (MID)
AF:
AC:
895
AN:
5732
European-Non Finnish (NFE)
AF:
AC:
121664
AN:
1109896
Other (OTH)
AF:
AC:
6930
AN:
60056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
6793
13586
20380
27173
33966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4480
8960
13440
17920
22400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.152 AC: 23150AN: 152178Hom.: 2445 Cov.: 32 AF XY: 0.149 AC XY: 11062AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
23150
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
11062
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
12262
AN:
41472
American (AMR)
AF:
AC:
1645
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
512
AN:
3472
East Asian (EAS)
AF:
AC:
4
AN:
5190
South Asian (SAS)
AF:
AC:
269
AN:
4822
European-Finnish (FIN)
AF:
AC:
632
AN:
10620
Middle Eastern (MID)
AF:
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7352
AN:
68000
Other (OTH)
AF:
AC:
314
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
968
1936
2904
3872
4840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
158
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.